Цикло 3 Форт

Quick links

Choose a section

Quick links to important sections

Advertisements

Цикло 3 Форт

Selected form

Advertisements
Advertisements

Method of action: Angioprotective

Treatment option:

Advertisements

Overview of Цикло 3 Форт

Property Description
Active Ingredients Ruscus aculeatus extract, Hesperidin methyl chalcone, Ascorbic acid (Vitamin C)
Form Hard capsules
Pharmacological Class Venoactive Drug, Vasculoprotective Agent
General Purpose Support venous tone and capillary resistance
Origin Phytotherapeutic and synthetic compound combination

What Type of Medicine is Цикло 3 Форт?

Цикло 3 Форт (Cyclo 3 Fort) is classified as a venoactive drug and a vasculoprotective agent, belonging to the larger pharmacological group known as phlebotonics, and is supplied as a fixed combination product in hard capsules for oral administration. This pharmaceutical preparation is designed to selectively influence the integrity and function of the venous system and microvessels. Its primary function as a venotonic means it acts to improve the tension and elasticity of the vein walls, while its vasculoprotective function reinforces the resilience of the capillaries.

This medicine is a recognized proprietary product, differentiating it from generic single-component venoactive preparations. The combination product status signifies that the capsule contains a precise, unvarying blend of three distinct active components which work synergistically for comprehensive vascular support.

What is the Composition of Цикло 3 Форт?

The active core of Цикло 3 Форт is a triad of substances: a dry extract derived from the rhizome of Ruscus aculeatus (Butcher's Broom), hesperidin methyl chalcone, and ascobic acid (Vitamin C). This formulation is a blend of derived natural (phytotherapeutic) and synthetic compounds. The efficacy of the Ruscus aculeatus extract, specifically in its ability to improve symptoms of chronic venous insufficiency, is clinically recognized. The addition of hesperidin methyl chalcone and ascobic acid contributes crucial support to capillary stability and the structural protein necessary for vascular wall integrity.

What is the General Purpose of Цикло 3 Форт?

The general purpose of Цикло 3 Форт is to support the overall health and function of the circulatory system, specifically aiming to enhance venous tone and increase capillary resistance. This is particularly relevant for managing discomfort associated with conditions where blood flow in the veins is compromised. By improving the strength and elasticity of blood vessel walls, the medicine helps to reduce the abnormal pooling of blood and minimize the leakage of fluid into the surrounding tissues. This combined effect is crucial for managing symptoms such as leg heaviness, tension, and excessive swelling (edema), which are typical manifestations of venous and microcirculatory dysfunction.

Regulatory References

  1. NIH MedlinePlus
Advertisements

What side effects are possible with Цикло 3 Форт?

Possible Side Effects and Safety Information

The safety profile of Цикло 3 Форт is structured according to regulatory standards, classifying adverse reactions by frequency and the body system affected. The most frequently documented side effects relate to the digestive system, while specific warnings address serious reactions and conditions where the medicine is prohibited.


Frequency-Classified Adverse Reactions

The official labeling organizes adverse events into frequency tiers. Common reactions (occurring in 1% to 10% of users) primarily include nausea, stomach pain (abdominal pain), and diarrhea. Reactions classified as Uncommon include dyspepsia, insomnia, dizziness (vertigo), pruritus (itching), and rash.

Reactions classified as Rare include headache, urticaria, and colitis, including lymphocytic colitis. Additionally, severe allergic reactions like Angioedema and other manifestations of hypersensitivity are documented with a Not known frequency.


System-Organ Class Involvement

The documented adverse reactions affect specific organ systems, notably Gastrointestinal disorders, Nervous system disorders, Skin and subcutaneous tissue disorders, and Immune system disorders.


Regulatory Safety Restrictions

Цикло 3 Форт is subject to several safety restrictions, designated as Contraindications in regulatory prescribing information. The medicine is contraindicated in individuals with known hypersensitivity to any of its components. It is also prohibited in cases of pre-existing disorders of iron storage (such as hemochromatosis) due to the presence of Ascorbic acid (Vitamin C) in the formulation.

Use is not recommended during pregnancy or lactation (breast-feeding) due to insufficient data on safety in these populations. The medicine is also not recommended for use in children.

Advertisements

Overdose and Emergency Response

The official regulatory profile for a potential overdose of Цикло 3 Форт (Ruscus aculeatus extract, Hesperidin methyl chalcone, Ascorbic acid) is primarily defined by the known toxicity of its components at massive doses. Documented overdose presentations largely involve severe gastrointestinal disturbances, including acute diarrhea, abdominal pain, nausea, and gastritis. These are the most common acute systemic manifestations.

A significant outcome documented by government health authorities relates to the Ascorbic acid (Vitamin C) component. Ingestion of very high doses is associated with a specific risk of severe renal complications, such as oxalate nephropathy and the formation of kidney stones. Furthermore, a risk of hemolysis exists for individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency following massive intake.

The mandated emergency response is clear: individuals must seek immediate medical attention or contact emergency services upon suspected overdose, or if any symptoms are severe or persistent. Urgent medical care is required if the person collapses, has a seizure, or cannot be awakened. Regulatory documents confirm that no specific antidote is known for this combination. Therefore, management is confined to symptomatic and supportive treatment with monitoring of vital signs and renal function often required in a clinical setting.

Advertisements

Therapeutic Uses of Цикло 3 Форт

Цикло 3 Форт is used in areas where short-term symptom management is appropriate and may be part of symptomatic relief across specific vascular and microcirculatory disorders. The medication is used in situations involving certain distressing symptoms and is applied across domains where additional symptomatic support is needed.

Regarding the key components of the medicine, use is based on traditional indications. The product is commonly used to help manage the functional signs of Chronic Venous Insufficiency (CVI), and is applied in addressing functional signs associated with an Acute Hemorrhoidal Crisis.

This supportive approach is relevant for easing symptom clusters that may become intense or disruptive, such as the persistent feeling of heaviness, aching, and fatigue in the lower limbs, edema (swelling), nocturnal calf muscle cramps, and local tension associated with acute episodes. The supportive approach may help ease the overall symptom burden and assists with maintaining functional stability when symptoms become more noticeable.


Quick Fact: Relief for Leg Heaviness

Quick Fact: Relief for Leg Heaviness Цикло 3 Форт is applied when symptoms intensify and supportive relief is needed, and it contributes to easing the overall symptom load during periods of heightened symptoms associated with poor venous return.

Regulatory References

  1. European Medicines Agency (EMA) overview on Rusci rhizoma (Butcher's Broom)
Advertisements

Eligibility and Restrictions for Use

Official regulatory documents establish clear restrictions on who is eligible to use Цикло 3 Форт. Use of this medicine is reserved for the adult population.


Contraindications (Must Not Use)

The medicine is strictly contraindicated and must not be used by individuals who fall into the following categories:

  • Patients with a known hypersensitivity or allergy to any of the active substances (Ruscus aculeatus extract, hesperidin methyl chalcone, ascorbic acid) or excipients.
  • Patients with specific disorders of iron metabolism (due to the Vitamin C component). This prohibition includes conditions such as thalassemia, hemochromatosis, and sideroblastic anemia.

Age and Physiological Restrictions

The regulatory profile explicitly excludes or limits use for certain demographics:

  • Children and Adolescents: The medicine is officially not intended for use in the pediatric population.
  • Pregnancy and Lactation: Use is officially not recommended for women who are pregnant or breastfeeding.

This eligibility profile is defined solely by the mandatory criteria found in official regulatory labeling.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Цикло 3 Форт is defined by the effects of one of its active components, Ascorbic acid (Vitamin C), as complex drug-drug metabolic interactions are not specified in the official regulatory labeling.

Interaction-Related Restrictions

The product carries a documented caution against use in individuals with iron storage disorders, such as hemochromatosis, thalassemia, or sideroblastic anemia. The Ascorbic acid component can increase the absorption of iron, leading to this population-specific restriction as listed in the regulatory documents.

Interactions with Diagnostic Tests

Ascorbic acid may influence the accuracy of certain biological tests and procedures. Specifically, the component is noted to interfere with measurements for blood glucose, bilirubin, transaminase activity, and lactates.

Pharmacokinetic and Drug-Drug Interactions

The official prescribing information does not document any clinically significant pharmacokinetic interactions with other medicines based on Cytochrome P450 enzymes or drug transporters. Similarly, no explicit interactions with food, alcohol, or common herbal products are documented, and no mandatory timing separation rules are listed.

Advertisements

Mechanism of Action

The pharmacological mechanism of Цикло 3 Форт involves the synergistic action of its components on the vascular system. The Ruscus aculeatus extract mediates a venoconstrictor effect by acting as an agonist at postsynaptic alpha1- and alpha2-adrenergic receptors on the venous smooth muscle cell membrane. This direct interaction, along with an indirect stimulation via displacement of stored norepinephrine from nerve endings, increases the tension of the venous wall. Hesperidin methyl chalcone acts primarily on the microcirculation by reducing capillary permeability. This action involves the stabilization of the microvascular endothelium and the minimization of fluid leakage into the surrounding tissue space. Ascorbic acid supports this effect by enhancing the resistance of the capillary walls and contributing to the integrity of the endothelial structure. Collectively, the combination modulates vascular function through three distinct mechanisms: adrenergic-mediated venular constriction, capillary permeability control, and increased capillary resistance. These actions produce a measurable change in venous and lymphatic fluid dynamics.

Advertisements

Dosage and Administration Information

The use of Цикло 3 Форт follows specific guidelines detailing the administration route, dosing ranges, and duration for adult patients. The medicine is formulated as a hard capsule intended exclusively for oral administration, and each capsule must be swallowed whole with a glass of water.

The standard dosing regimen is dependent on the condition being addressed. For managing functional signs associated with venous insufficiency, the dose is typically 2 to 3 capsules per day. During an acute hemorrhoidal crisis, a higher dose of 4 to 5 capsules per day is specified.

In both scenarios, the total daily dose is intended to be administered in divided doses. To manage potential gastrointestinal discomfort, the capsule is advised to be taken at the start of a meal. Due to the presence of Ascorbic acid (Vitamin C) in the formulation, it is recommended to avoid administration after 4 p.m. Furthermore, if a dose is missed, a double dose should not be taken to compensate.

The duration of use is defined as short-term. Use for acute hemorrhoidal episodes should not exceed one week. For symptoms of venous insufficiency, the course is typically reviewed if symptoms persist after 15 days of continuous use.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Цикло 3 Форт

Evidence for use in Chronic Venous Insufficiency (CVI)

Цикло 3 Форт was studied for conditions marked by functional limitations and characterized by fluctuating symptoms of chronic venous insufficiency (CVI). The research examined how these symptoms change over time. Many of these studies were designed as randomized, placebo-controlled trials.

Studies reported measurements of patient-reported outcomes describing perceived discomfort, such as the feelings of leg heaviness, pain, and nocturnal cramps. Research also monitored physiological strain or stress by assessing changes in measurements like venous capacity and limb circumference. Objective outcomes related to systemic or functional imbalance, such as venous capacity, were also monitored. Objective measures of physiological strain were reported with varied findings across studies.

Findings contribute to understanding symptom patterns, but results apply only to the populations studied, and evidence quality varies across studies.


Evidence for use in Acute Hemorrhoidal Crisis

Research has explored the use of Цикло 3 Форт as an auxiliary treatment for conditions involving periods of heightened symptoms, specifically during an acute hemorrhoidal crisis. Clinical information for this indication is often derived from the Traditional Use designation for the primary herbal component.

Research exploring short-term symptom changes reports on patterns of symptoms observed in the populations over defined, limited time intervals. The evidence highlights findings related to how patients reported their experience during episodes where symptoms became more noticeable.

Follow-up durations were limited in these research scenarios. The evidence focuses on short-term symptom changes related to the acute phase of the condition.


Evidence Quality, Gaps, and Uncertainty

Data show patterns related to patient-reported outcomes; the research provides context but not individual predictions. Research describes what has been observed so far, noting what is still uncertain, particularly concerning long-term use and the response in diverse patient groups. Certainty remains low in areas where comparative evidence is lacking or sample sizes were modest. Data for certain groups, such as children and pregnant individuals, remains insufficient.

Key Studies & References Ascorbic Acid (Vitamin C) - MedlinePlus Reference (NIH)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Цикло 3 Форт (FAQ)

Q: How does the Ruscus extract component in Цикло 3 Форт generally function?

Official regulatory documents describe the Ruscus extract component as having a venoconstrictor effect. This means its action is described as increasing the tension of the vein walls. This is mediated through its effect on the alpha1- and alpha2-adrenergic receptors found on the smooth muscle cells of the veins.

Q: Are there any known side effects related to the nervous system, such as insomnia or nervousness?

The official list of adverse reactions includes some effects related to the nervous system. Insomnia (difficulty sleeping) and dizziness (vertigo) are classified as Uncommon side effects. Nervousness is not explicitly listed in the official adverse reaction profile.

Q: Can taking Цикло 3 Форт cause dizziness or drowsiness?

According to official product information, dizziness (vertigo) is a documented Uncommon side effect. However, the regulatory information does not explicitly list drowsiness as a known adverse reaction.

Q: Can Цикло 3 Форт be taken simultaneously with other medications for stomach issues or reflux (e.g., PPIs)?

The official prescribing information does not document any clinically significant drug-drug metabolic interactions. No mandatory timing separation rules are listed for taking the medicine alongside common medications, including those for stomach issues or reflux.

Q: Does the medicine contain any ingredients that could cause an allergic reaction, such as a dye?

Official warnings state that the capsule contains the excipient Orange Yellow S (E110), which is an azo dye and may cause allergic reactions. Regulatory documents also list general Hypersensitivity reactions, including severe swelling (Angioedema), as possible adverse reactions.

Q: Is there any known risk of overdose with this medication?

The official regulatory information addresses the risk of overdose, stating that no case of overdose has been reported for this medication.

Q: Can Цикло 3 Форт be taken with contraceptive pills?

Official documents do not specify any interaction between Цикло 3 Форт and oral contraceptives or mention a reduction in their effectiveness.

Q: What is the expected maximum duration of use for Цикло 3 Форт, according to official information?

The duration of use is defined as short-term. For symptoms of venous insufficiency, the course is typically reviewed if symptoms persist after 15 days. For an acute hemorrhoidal crisis, treatment is officially specified not to exceed one week.

Q: Can Цикло 3 Форт be used for long-term support of vein health?

The official regulatory documents describe the duration of use as short-term. The regulatory label does not contain a recommended dosing schedule for extended or long-term administration.

Q: Is there a risk of developing a stomach or intestinal issue like colitis while taking Цикло 3 Форт?

Yes, official safety information lists specific gastrointestinal reactions. Colitis, including lymphocytic colitis (an intestinal inflammation), is documented as a Rare adverse reaction.

Q: Does the vitamin C content in Цикло 3 Форт interact with iron storage conditions?

The presence of Ascorbic acid (Vitamin C) in the formulation is why the medicine is contraindicated in individuals with iron storage disorders, such as hemochromatosis. This is based on the component's known action to increase the body's absorption of iron, which leads to the contraindication in these conditions.

Q: Is it acceptable to consume alcohol while undergoing treatment with Цикло 3 Форт?

Official prescribing information does not document any explicit interaction or mandatory restriction regarding the consumption of alcohol while using this medicine.

Q: Does official information address whether Цикло 3 Форт affects the ability to drive or use machines?

Official labeling explicitly addresses this concern, stating that the medicine is considered to have no or negligible influence on the patient's ability to drive and use heavy machinery.

Q: Why does the leaflet mention discontinuing the treatment if severe diarrhea occurs?

The official warning explicitly advises patients to stop the treatment and inform their doctor in the case of severe or persistent diarrhea.

Q: Can the ingredients in Цикло 3 Форт affect the results of blood tests, such as glucose or bilirubin measurements?

Yes, the Ascorbic acid (Vitamin C) component is noted to influence or interfere with the results of certain biological tests. This includes measurements for blood glucose, bilirubin, lactates, and specific enzyme activities.

Q: Does the presence of a colorant (azo dye) in the capsule have any health implications?

The capsule contains the azo dye Orange Yellow S (E110), and regulatory information states this component may cause allergic reactions in some individuals.

Q: Does taking the capsule with food affect how well it works?

The official instruction advises taking the capsule at the start of a meal. This recommendation is specifically in place to manage potential gastrointestinal discomfort, but the information does not state that food intake improves the medicine's efficacy (how well it works).

Q: What should be done if an adverse effect is suspected after taking the medicine?

Standard patient information states that if a patient suspects they have experienced an adverse effect, they should consult their doctor or pharmacist and/or report it to the national health authority.

Q: What should a patient do if they miss a dose?

Official guidance explicitly states that a double dose should not be taken to compensate for a forgotten dose. Instead, the patient should continue with the next scheduled dose at the usual time.

Q: Does the effectiveness of Цикло 3 Форт depend on lifestyle changes?

The regulatory documents explicitly state that the maximum benefit of the medication is achieved when it is combined with a healthy lifestyle. This includes avoiding exposure to heat, prolonged standing, and managing excess weight.

Q: Are there non-gastrointestinal side effects, such as skin reactions or itching?

The official side effect profile lists adverse reactions affecting the skin. These include pruritus (itching) and rash, which are classified as Uncommon reactions, and urticaria (hives), classified as a Rare reaction.

Q: Can this medication be used alongside common pain relievers like paracetamol or ibuprofen?

The official prescribing information states that no clinically significant pharmacokinetic interactions are documented. This suggests no explicit interaction warning for common drug classes like typical pain relievers.

Advertisements

How should Цикло 3 Форт be stored and disposed of?

How to Store and Dispose of Цикло 3 Форт?

The storage and disposal of Цикло 3 Форт are defined by official regulatory requirements to ensure the stability of the hard capsules and environmental safety.

Official Storage Requirements

Condition Requirement
Temperature Store at a temperature below 25 C (77 F).
Packaging Keep the medicine in its original container.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Official regulations strictly forbid discarding this medicine through ordinary household waste or wastewater. Unused or expired capsules must be returned to a pharmacist or designated pharmaceutical waste collection point for safe and environmentally compliant disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Цикло 3 Форт found in:

A-Z Index: